James Russell
Corporate Officer/Principal at University of British Columbia
Profile
Mr. James Russell is Co-Founder at Sirius Genomics, Inc., a Professor at University of British Columbia, and an Associate Director-Intensive Care Unit at St. Paul's Hospital.
He received his doctorate degree from the University of Toronto.
James Russell active positions
| Companies | Position | Start |
|---|---|---|
| University of British Columbia | Corporate Officer/Principal | 2009-11-12 |
St. Paul's Hospital
 St. Paul's Hospital Hospital/Nursing ManagementHealth Services St. Paul's Hospital operates a medical hospital. The private company is based in Hong Kong, Hong Kong. | Corporate Officer/Principal | - |
Former positions of James Russell
| Companies | Position | End |
|---|---|---|
Sirius Genomics, Inc.
 Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Founder | - |
Training of James Russell
| University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
St. Paul's Hospital
St. Paul's Hospital Hospital/Nursing ManagementHealth Services St. Paul's Hospital operates a medical hospital. The private company is based in Hong Kong, Hong Kong. | Health Services |
- Stock Market
- Insiders
- James Russell